Table 3: Summary of pooled hazard ratios for overall survival according to molecular biomarkers (HR <1 indicates improved survival, whereas HR >1 indicates poorer survival).

Molecular Marker

No. of Studies

Patients (n)

HR

95% CI

p-value

I² (%)

IDH Mutation

24

8,934

0.59

0.48-0.72

<0.001

32.2

1p/19q Codeletion

18

6,521

0.38

0.28-0.52

<0.001

27.4

CDKN2A/B Deletion

11

3,912

1.82

1.44-2.31

<0.001

35.1

TERT Promoter Mutation

13

4,801

1.41

1.12-1.79

0.003

41.8

EGFR Amplification

9

3,455

1.65

1.26-2.17

<0.001

38.5

+7/−10 Signature

7

2,611

1.72

1.29-2.30

<0.001

30.4